1 follower
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together wi... Read more
Kura Oncology
20 followers
Halozyme Therapeutics
6 followers
Immunovant
6 followers
REVOLUTION Medicines
5 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
Inari
3 followers
Beta Bionics
3 followers
Arcturus Therapeutics
2 followers
Tenaya Therapeutics
2 followers
Generation Bio
2 followers
Explore companies